Perspective Therapeutics CATX Gross margin
Gross margin at other companies
Other financials
Where this comes from
Calculated from Perspective Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Perspective Therapeutics’s 10-Q, filed November 12, 2024, on SEC EDGAR. View the filing →
Ask your AI about Perspective Therapeutics's gross margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Perspective Therapeutics's gross margin?
- Perspective Therapeutics (CATX) reported gross margin of 33.1% in Q3 2023.
- How has Perspective Therapeutics's gross margin changed year-over-year?
- Perspective Therapeutics's gross margin decreased by 17.7% year-over-year, from 40.2% to 33.1%.
- What is the long-term trend for Perspective Therapeutics's gross margin?
- Over 2 years (2020 to 2022), Perspective Therapeutics's gross margin has grown at a -10.7% compound annual growth rate (CAGR), from 53.6% to 42.8%.
- What does gross margin mean?
- Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.